Incentive Stock Programs

9 Months Ended

Sep. 30, 2023

Share-Based Payment Arrangement [Abstract]

Note 9 — Incentive Stock Programs

In the first nine months of 2023, Abbott granted 1,986,671 stock options, 463,856 restricted stock awards and 4,927,476 restricted stock units under its incentive stock program. At September 30, 2023, approximately 74 million shares were reserved for future grants. Information regarding the number of options outstanding and exercisable at September 30, 2023 is as follows:


	Outstanding		Exercisable
Number of shares	29,342,041		24,718,236
Weighted average remaining life (years)	5.0		4.3
Weighted average exercise price	$	73.77	$	66.27
Aggregate intrinsic value (in millions)	$	825	$	825

The total unrecognized share-based compensation cost at September 30, 2023 amounted to approximately $560 million which is expected to be recognized over the next three years.